Novo expects sales to fall in 2026, triggering selloff
诺和诺德预期2026年销售下滑，引发抛售

Novo Nordisk expects its sales to shrink by at least 5% this year, citing negative pricing dynamics, including its deal with the US government.
诺和诺德预计今年销售额将至少下降5%，理由是定价环境不利，其中包括其与美国政府达成的协议。